The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Gold nanoparticles: Emerging paradigm for targeted drug delivery system
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744 · cited 2×
“…N C O R R E C factor-1(GF-1), phosphatidylinositol 3-kinases (PI3K) andmitogen activated protein kinases (MAPK) signaling pathway, whichwere generally considered as carcinogenic (Cairns et al., 2011; Vander Heiden et al., 2009).”
BackgroundDrug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · cited 1×
“For instance, drug localization, decreased side effects, reduced dosage, modulated pharmacokinetics, controlled biodistribution, and most importantly, improved patient's compliance (Allen and Cullis, 2004; Farokhzad and Langer, 2009).”
BackgroundTargeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609 · cited 1×
“P-gp is responsible for nearly 50% of resistance, and one of the most well studied strategies is to inhibit the P-gp activity (Szakacs et al., 2006).”
BackgroundThe golden age: gold nanoparticles for biomedicine
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El-Sayed, M. A. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15237h · Cited by 3,550
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Nanoparticle-mediated cellular response is size-dependent
Jiang, W., Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.30 · Cited by 2,776
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,463
Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity
Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J., & Wyatt, M. D. (2005) · Small · doi:10.1002/smll.200400093 · Cited by 2,406
Gold Nanoparticles for Biology and Medicine
Giljohann, D. A., Seferos, D. S., Daniel, W. L., Massich, M. D., Patel, P. C., & Mirkin, C. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200904359 · Cited by 2,356
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201 · cited 4×
“Product/brand name Component/active ingredient Delivery route Target Company Current status t2:4 Verigene Gold In-vitro diagnostic Genetics Nanosphere FDA-approved t2:5 Aurimmune Colloidal gold nanoparticles coupled to TNF-α and PEG-Thiol (~27 nm) Intravenous Solid tumor Cyt-Immune Sciences Phase-II t2:6 AuroShell Gol…”
BackgroundInfluentialGold nanorods: Synthesis, characterization and applications
Pérez-Juste, J., Pastoriza-Santos, I., Liz-Marzán, L. M., & Mulvaney, P. (2005) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2005.01.030 · Cited by 2,182
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116 · cited 1×
“Also, the lactic acid production often results in low pH environment, which in turn promote cancer cell proliferation and drug resistance (Hu and Zhang, 2009;Montopoli et al., 2011; Tredan et al., 2007).”
BackgroundGold nanoparticles in biomedical applications: recent advances and perspectives
Dykman, L., & Khlebtsov, N. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15166e · Cited by 1,961
Kerbel, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706596 · Cited by 1,948
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
Size‐Dependent Cytotoxicity of Gold Nanoparticles
Pan, Y., Neuss, S., Leifert, A., Fischler, M., Wen, F., Simon, U., Schmid, G., Brandau, W., & Jahnen‐Dechent, W. (2007) · Small · doi:10.1002/smll.200700378 · Cited by 1,878
Shukla, R., Bansal, V., Chaudhary, M., Basu, A., Bhonde, R. R., & Sastry, M. (2005) · Langmuir · doi:10.1021/la0513712 · Cited by 1,687
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration
De Jong, W. H., Hagens, W. I., Krystek, P., Burger, M. C., Sips, A. J. A. M., & Geertsma, R. E. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.037 · Cited by 1,615
Khlebtsov, N., & Dykman, L. (2011) · Chem. Soc. Rev. · doi:10.1039/c0cs00018c · Cited by 1,584
Paul Ehrlich's magic bullet concept: 100 years of progress
Strebhardt, K., & Ullrich, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2394 · Cited by 1,457
Physical approaches to biomaterial design
Mitragotri, S., & Lahann, J. (2009) · Nature Materials · doi:10.1038/nmat2344 · Cited by 1,445
Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles
Verma, A., Uzun, O., Hu, Y., Hu, Y., Han, H.-S., Watson, N., Chen, S., Irvine, D. J., & Stellacci, F. (2008) · Nature Materials · doi:10.1038/nmat2202 · Cited by 1,266
Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers
Champion, J. A., Katare, Y. K., & Mitragotri, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.022 · Cited by 1,206
Kim, S.-H., Turnbull, J., & Guimond, S. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0377 · Cited by 1,166
Optical Properties of Star-Shaped Gold Nanoparticles
Nehl, C. L., Liao, H., & Hafner, J. H. (2006) · Nano Letters · doi:10.1021/nl052409y · Cited by 1,162
Treating metastatic cancer with nanotechnology
Schroeder, A., Heller, D. A., Winslow, M. M., Dahlman, J. E., Pratt, G. W., Langer, R., Jacks, T., & Anderson, D. G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3180 · Cited by 1,159
Sonavane, G., Tomoda, K., & Makino, K. (2008) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2008.07.004 · Cited by 1,100
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
Alkilany, A. M., Nagaria, P. K., Hexel, C. R., Shaw, T. J., Murphy, C. J., & Wyatt, M. D. (2009) · Small · doi:10.1002/smll.200801546 · Cited by 1,029
Chen, J., Wang, D., Xi, J., Au, L., Siekkinen, A., Warsen, A., Li, Z.-Y., Zhang, H., Xia, Y., & Li, X. (2007) · Nano Letters · doi:10.1021/nl070345g · Cited by 1,025
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
Qian, Z. M., Li, H., Sun, H., & Ho, K. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.561 · Cited by 1,019
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,006
Toxicology of nanoparticles: A historical perspective
Oberdörster, G., Stone, V., & Donaldson, K. (2007) · Nanotoxicology · doi:10.1080/17435390701314761 · Cited by 964
Targeting nanoparticles to cancer
Wang, M., & Thanou, M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.03.005 · Cited by 931
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Bates, P. J., Laber, D. A., Miller, D. M., Thomas, S. D., & Trent, J. O. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.004 · Cited by 874
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
Brown, S. D., Nativo, P., Smith, J.-A., Stirling, D., Edwards, P. R., Venugopal, B., Flint, D. J., Plumb, J. A., Graham, D., & Wheate, N. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908117a · Cited by 865
Huang, K., Ma, H., Liu, J., Huo, S., Kumar, A., Wei, T., Zhang, X., Jin, S., Gan, Y., Wang, P. C., et al. (2012) · ACS Nano · doi:10.1021/nn301282m · Cited by 840
Self-citationTargeting of drugs and nanoparticles to tumors
Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910104 · Cited by 829
Gold Nanocages: From Synthesis to Theranostic Applications
Xia, Y., Li, W., Cobley, C. M., Chen, J., Xia, X., Zhang, Q., Yang, M., Cho, E. C., & Brown, P. K. (2011) · Accounts of Chemical Research · doi:10.1021/ar200061q · Cited by 810
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 802
Gold nanostructures: a class of multifunctional materials for biomedical applications
Cobley, C. M., Chen, J., Cho, E. C., Wang, L. V., & Xia, Y. (2011) · Chem. Soc. Rev. · doi:10.1039/b821763g · Cited by 792
Baselga, J., Pfister, D., Cooper, M. R., Cohen, R., Burtness, B., Bos, M., D’Andrea, G., Seidman, A., Norton, L., Gunnett, K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.904 · Cited by 741
Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53
Chin, K.-V., Ueda, K., Pastan, I., & Gottesman, M. M. (1992) · Science · doi:10.1126/science.1346476 · Cited by 726
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Libutti, S. K., Paciotti, G. F., Byrnes, A. A., Alexander, H. R., Gannon, W. E., Walker, M., Seidel, G. D., Yuldasheva, N., & Tamarkin, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0978 · Cited by 710
Soenen, S. J., Rivera-Gil, P., Montenegro, J.-M., Parak, W. J., De Smedt, S. C., & Braeckmans, K. (2011) · Nano Today · doi:10.1016/j.nantod.2011.08.001 · Cited by 699
Assessment of the In Vivo Toxicity of Gold Nanoparticles
Chen, Y.-S., Hung, Y.-C., Liau, I., & Huang, G. S. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-009-9334-6 · Cited by 695
Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods
Qiu, Y., Liu, Y., Wang, L., Xu, L., Bai, R., Ji, Y., Wu, X., Zhao, Y., Li, Y., & Chen, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.051 · Cited by 689
Ma, X., Wu, Y., Jin, S., Tian, Y., Zhang, X., Zhao, Y., Yu, L., & Liang, X.-J. (2011) · ACS Nano · doi:10.1021/nn202155y · Cited by 628
Self-citationRemotely Triggerable Drug Delivery Systems
Timko, B. P., Dvir, T., & Kohane, D. S. (2010) · Advanced Materials · doi:10.1002/adma.201002072 · Cited by 614
Beating cancer in multiple ways using nanogold
Dreaden, E. C., Mackey, M. A., Huang, X., Kang, B., & El-Sayed, M. A. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00180e · Cited by 605
Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
Chauhan, V. P., Stylianopoulos, T., Boucher, Y., & Jain, R. K. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114300 · Cited by 597
Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice
Lasagna-Reeves, C., Gonzalez-Romero, D., Barria, M. A., Olmedo, I., Clos, A., Sadagopa Ramanujam, V. M., Urayama, A., Vergara, L., Kogan, M. J., & Soto, C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.046 · Cited by 584
Autophagy and oxidative stress associated with gold nanoparticles
Li, J. J., Hartono, D., Ong, C.-N., Bay, B.-H., & Yung, L.-Y. L. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.014 · Cited by 544
Tong, L., Wei, Q., Wei, A., & Cheng, J. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00507.x · Cited by 543
Recent advances in stealth coating of nanoparticle drug delivery systems
Amoozgar, Z., & Yeo, Y. (2012) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1157 · Cited by 528
Tuning Size and Sensing Properties in Colloidal Gold Nanostars
Barbosa, S., Agrawal, A., Rodríguez-Lorenzo, L., Pastoriza-Santos, I., Alvarez-Puebla, R. A., Kornowski, A., Weller, H., & Liz-Marzán, L. M. (2010) · Langmuir · doi:10.1021/la102559e · Cited by 522
Yoo, J.-W., Chambers, E., & Mitragotri, S. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791920496 · Cited by 521
Wang, L., Liu, Y., Li, W., Jiang, X., Ji, Y., Wu, X., Xu, L., Qiu, Y., Zhao, K., Wei, T., et al. (2011) · Nano Letters · doi:10.1021/nl103992v · Cited by 514
Remotely Triggered Liposome Release by Near-Infrared Light Absorption via Hollow Gold Nanoshells
Wu, G., Mikhailovsky, A., Khant, H. A., Fu, C., Chiu, W., & Zasadzinski, J. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja802656d · Cited by 500
Nanoparticles that communicate in vivo to amplify tumour targeting
Park, J., Lin, K., Singh, N., Schwöppe, C., Mesters, R. M., Berdel, W. E., Ruoslahti, E. I., Sailor, M. J., von Maltzhan, G., & Bhatia, S. N. (2010) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 500
A tumor-homing peptide with a targeting specificity related to lymphatic vessels
Laakkonen, P., Porkka, K., Hoffman, J. A., & Ruoslahti, E. (2002) · Nature Medicine · doi:10.1038/nm720 · Cited by 498
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels
Christian, S., Pilch, J., Akerman, M. E., Porkka, K., Laakkonen, P., & Ruoslahti, E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304132 · Cited by 497
Kievit, F. M., & Zhang, M. (2011) · Advanced Materials · doi:10.1002/adma.201102313 · Cited by 496
Dromi, S., Frenkel, V., Luk, A., Traughber, B., Angstadt, M., Bur, M., Poff, J., Xie, J., Libutti, S. K., Li, K. C. P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2443 · Cited by 492
Toxicologic effects of gold nanoparticles in vivo by different administration routes
Zhang (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s8428 · Cited by 490
Paciotti, G. F., Kingston, D. G. I., & Tamarkin, L. (2006) · Drug Development Research · doi:10.1002/ddr.20066 · Cited by 484
Visible Light-Induced Charge Retention and Photocatalysis with Hybrid CdSe−Au Nanodumbbells
Costi, R., Saunders, A. E., Elmalem, E., Salant, A., & Banin, U. (2008) · Nano Letters · doi:10.1021/nl0730514 · Cited by 478
Emerging implications of nanotechnology on cancer diagnostics and therapeutics
Cuenca, A. G., Jiang, H., Hochwald, S. N., Delano, M., Cance, W. G., & Grobmyer, S. R. (2006) · Cancer · doi:10.1002/cncr.22035 · Cited by 475
Gold Nanoparticles: A Revival in Precious Metal Administration to Patients
Thakor, A. S., Jokerst, J., Zavaleta, C., Massoud, T. F., & Gambhir, S. S. (2011) · Nano Letters · doi:10.1021/nl202559p · Cited by 468
Light‐Activated Nanoimpeller‐Controlled Drug Release in Cancer Cells
Lu, J., Choi, E., Tamanoi, F., & Zink, J. I. (2008) · Small · doi:10.1002/smll.200700903 · Cited by 462
CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport
Pardridge, W. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051781.x · Cited by 460
Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer
Patra, C. R., Bhattacharya, R., Mukhopadhyay, D., & Mukherjee, P. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.007 · Cited by 458
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W., & Cheresh, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803728105 · Cited by 455
Chen, C.-C., Lin, Y.-P., Wang, C.-W., Tzeng, H.-C., Wu, C.-H., Chen, Y.-C., Chen, C.-P., Chen, L.-C., & Wu, Y.-C. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0570180 · Cited by 424
Strategy for effective brain drug delivery
Alam, M. I., Beg, S., Samad, A., Baboota, S., Kohli, K., Ali, J., Ahuja, A., & Akbar, M. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.05.003 · Cited by 415
Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer's disease
Roney, C., Kulkarni, P., Arora, V., Antich, P., Bonte, F., Wu, A., Mallikarjuana, N. N., Manohar, S., Liang, H.-F., Kulkarni, A. R., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.024 · Cited by 406
Inorganic Nanoparticles in Cancer Therapy
Bhattacharyya, S., Kudgus, R. A., Bhattacharya, R., & Mukherjee, P. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0318-0 · Cited by 395
Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
Patra, C. R., Bhattacharya, R., Wang, E., Katarya, A., Lau, J. S., Dutta, S., Muders, M., Wang, S., Buhrow, S. A., Safgren, S. L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6102 · Cited by 371
Wang, X., Qian, X., Beitler, J. J., Chen, Z. G., Khuri, F. R., Lewis, M. M., Shin, H. J. C., Nie, S., & Shin, D. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3069 · Cited by 358
Molecular Biology and Pathology of Lymphangiogenesis
Karpanen, T., & Alitalo, K. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151515 · Cited by 356
Hu, K., Li, J., Shen, Y., Lu, W., Gao, X., Zhang, Q., & Jiang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.016 · Cited by 354
Mitochondrial/Cell-Surface Protein p32/gC1qR as a Molecular Target in Tumor Cells and Tumor Stroma
Fogal, V., Zhang, L., Krajewski, S., & Ruoslahti, E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6752 · Cited by 346
Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment
Kumar, A., Ma, H., Zhang, X., Huang, K., Jin, S., Liu, J., Wei, T., Cao, W., Zou, G., & Liang, X.-J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.058 · Cited by 315
Self-citationDesigner nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers
Caldorera-Moore, M., Guimard, N., Shi, L., & Roy, K. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903579971 · Cited by 304
Life as a Nanoscale Phenomenon
Mann, S. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705538 · Cited by 303
Expression of Follicle-Stimulating Hormone Receptor in Tumor Blood Vessels
Radu, A., Pichon, C., Camparo, P., Antoine, M., Allory, Y., Couvelard, A., Fromont, G., Hai, M. T. V., & Ghinea, N. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001283 · Cited by 302
Integrin signalling adaptors: not only figurants in the cancer story
Cabodi, S., del Pilar Camacho-Leal, M., Di Stefano, P., & Defilippi, P. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2967 · Cited by 291
(2004) · The Women's Oncology Review · doi:10.3109/14733400410001727592 · Cited by 288
In Vitro Blood–Brain Barrier Models: Current and Perspective Technologies
Naik, P., & Cucullo, L. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23022 · Cited by 288
Remotely Triggered Release from Magnetic Nanoparticles
Derfus, A. M., von Maltzahn, G., Harris, T. J., Duza, T., Vecchio, K. S., Ruoslahti, E., & Bhatia, S. N. (2007) · Advanced Materials · doi:10.1002/adma.200700091 · Cited by 282
Chang, M., Shiau, A., Chen, Y., Chang, C., Chen, H. H., & Wu, C. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00827.x · Cited by 281
Eck, W., Craig, G., Sigdel, A., Ritter, G., Old, L. J., Tang, L., Brennan, M. F., Allen, P. J., & Mason, M. D. (2008) · ACS Nano · doi:10.1021/nn800429d · Cited by 280
Direct Observation of Nanoparticle–Cancer Cell Nucleus Interactions
Dam, D. H. M., Lee, J. H., Sisco, P. N., Co, D. T., Zhang, M., Wasielewski, M. R., & Odom, T. W. (2012) · ACS Nano · doi:10.1021/nn300296p · Cited by 276
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells
Laakkonen, P., Åkerman, M. E., Biliran, H., Yang, M., Ferrer, F., Karpanen, T., Hoffman, R. M., & Ruoslahti, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403317101 · Cited by 275
Yoo, J.-W., Doshi, N., & Mitragotri, S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.004 · Cited by 272
Dreaden, E. C., Mwakwari, S. C., Sodji, Q. H., Oyelere, A. K., & El-Sayed, M. A. (2009) · Bioconjugate Chemistry · doi:10.1021/bc9002212 · Cited by 268
Pathania, D., Millard, M., & Neamati, N. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.010 · Cited by 263
Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis
Liang, X.-J., Meng, H., Wang, Y., He, H., Meng, J., Lu, J., Wang, P. C., Zhao, Y., Gao, X., Sun, B., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909707107 · Cited by 256
Self-citationMagnetically Triggered Nanocomposite Membranes: A Versatile Platform for Triggered Drug Release
Hoare, T. R., Timko, B. P., Santamarı́a, J., et al. (2011) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 256
Nanoparticle Imaging of Integrins on Tumor Cells
Montet, X., Montet-Abou, K., Reynolds, F., Weissleder, R., & Josephson, L. (2006) · Neoplasia · doi:10.1593/neo.05769 · Cited by 251
Magnetically Triggered Nanocomposite Membranes: A Versatile Platform for Triggered Drug Release
Hoare, T., Timko, B. P., Santamaria, J., Goya, G. F., Irusta, S., Lau, S., Stefanescu, C. F., Lin, D., Langer, R., & Kohane, D. S. (2011) · Nano Letters · doi:10.1021/nl200494t · Cited by 247
Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma
Kelly, K. A., Bardeesy, N., Anbazhagan, R., Gurumurthy, S., Berger, J., Alencar, H., DePinho, R. A., Mahmood, U., & Weissleder, R. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050085 · Cited by 240
Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility.
Schroeder, A., Avnir, Y., Weisman, S., Najajreh, Y., Gabizon, A., Talmon, Y., Kost, J., & Barenholz, Y. (2007) · Langmuir · doi:10.1021/la0631668 · Cited by 239
Cooperative Nanoparticles for Tumor Detection and Photothermally Triggered Drug Delivery
Park, J., von Maltzahn, G., Ong, L. L., Centrone, A., Hatton, T. A., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Advanced Materials · doi:10.1002/adma.200902895 · Cited by 238
The Metabolism of Neuronal Iron and Its Pathogenic Role in Neurological Disease: Review
MOOS, T., & MORGAN, E. H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.002 · Cited by 234
Therapeutic Nanoparticles to Combat Cancer Drug Resistance
Hu, C.-M., & Zhang, L. (2009) · Current Drug Metabolism · doi:10.2174/138920009790274540 · Cited by 223
Diagaradjane, P., Shetty, A., Wang, J. C., Elliott, A. M., Schwartz, J., Shentu, S., Park, H. C., Deorukhkar, A., Stafford, R. J., Cho, S. H., et al. (2008) · Nano Letters · doi:10.1021/nl080496z · Cited by 215
Guo, L., Von Dem Bussche, A., Buechner, M., Yan, A., Kane, A. B., & Hurt, R. H. (2008) · Small · doi:10.1002/smll.200700754 · Cited by 214
Mishra, A., Tripathy, S. K., Wahab, R., Jeong, S.-H., Hwang, I., Yang, Y.-B., Kim, Y.-S., Shin, H.-S., & Yun, S.-I. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3556-0 · Cited by 211
Akiyama, Y., Mori, T., Katayama, Y., & Niidome, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.006 · Cited by 210
Nuclear delivery of macromolecules: barriers and carriers
BELTING, M., SANDGREN, S., & WITTRUP, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.004 · Cited by 209
Integrin signalling and function in immune cells
Zhang, Y., & Wang, H. (2012) · Immunology · doi:10.1111/j.1365-2567.2011.03549.x · Cited by 206
Bonoiu, A. C., Mahajan, S. D., Ding, H., Roy, I., Yong, K.-T., Kumar, R., Hu, R., Bergey, E. J., Schwartz, S. A., & Prasad, P. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901715106 · Cited by 204
Dufort, S., Sancey, L., & Coll, J.-L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.009 · Cited by 200
Ward, P. S., Cross, J. R., Lu, C., Weigert, O., Abel-Wahab, O., Levine, R. L., Weinstock, D. M., Sharp, K. A., & Thompson, C. B. (2012) · Oncogene · doi:10.1038/onc.2011.416 · Cited by 191
Growth of Gold Nanoparticles in Human Cells
Anshup, Venkataraman, J. S., Subramaniam, C., Kumar, R. R., Priya, S., Kumar, T. R. S., Omkumar, R. V., John, A., & Pradeep, T. (2005) · Langmuir · doi:10.1021/la0519249 · Cited by 191
Buyukhatipoglu, K., & Clyne, A. M. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32972 · Cited by 188
Multifunctional Nanocarriers for Cell Imaging, Drug Delivery, and Near-IR Photothermal Therapy
Guo, R., Zhang, L., Qian, H., Li, R., Jiang, X., & Liu, B. (2010) · Langmuir · doi:10.1021/la903893n · Cited by 188
Recht, L., Torres, C. O., Smith, T. W., Raso, V., & Griffin, T. W. (1990) · Journal of Neurosurgery · doi:10.3171/jns.1990.72.6.0941 · Cited by 185
Garanger, E., Boturyn, D., & Dumy, P. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007781668706 · Cited by 185
Liu, H., Liu, T., Wu, X., Li, L., Tan, L., Chen, D., & Tang, F. (2012) · Advanced Materials · doi:10.1002/adma.201103343 · Cited by 178
Enzymatically controlled drug delivery.
Fischel-Ghodsian, F., Brown, L., Mathiowitz, E., Brandenburg, D., & Langer, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2403 · Cited by 176
Wang, C., & Irudayaraj, J. (2010) · Small · doi:10.1002/smll.200901596 · Cited by 176
Gold-doxorubicin nanoconjugates for overcoming multidrug resistance
Gu, Y.-J., Cheng, J., Man, C. W.-Y., Wong, W.-T., & Cheng, S. H. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.06.005 · Cited by 171
Assessing Iron Oxide Nanoparticle Toxicity In Vitro : Current Status and Future Prospects
Soenen, S. J., & Cuyper, M. D. (2010) · Nanomedicine · doi:10.2217/nnm.10.106 · Cited by 167
HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer Therapy
Alexis, F., Basto, P., Levy‐Nissenbaum, E., Radovic‐Moreno, A. F., Zhang, L., Pridgen, E., Wang, A. Z., Marein, S. L., Westerhof, K., Molnar, L. K., et al. (2008) · ChemMedChem · doi:10.1002/cmdc.200800122 · Cited by 164
Peptide‐mediated targeted drug delivery
Majumdar, S., & Siahaan, T. J. (2010) · Medicinal Research Reviews · doi:10.1002/med.20225 · Cited by 163
Freed, E., Gailit, J., van der Geer, P., Ruoslahti, E., & Hunter, T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08445.x · Cited by 161
Nanoparticle-mediated thermal therapy: Evolving strategies for prostate cancer therapy
Krishnan, S., Diagaradjane, P., & Cho, S. H. (2010) · International Journal of Hyperthermia · doi:10.3109/02656736.2010.485593 · Cited by 160
Site-Directed Pegylation of Recombinant Interleukin-2 at its Glycosylation Site
Goodson, R. J., & Katre, N. V. (1990) · Nature Biotechnology · doi:10.1038/nbt0490-343 · Cited by 159
Subchronic inhalation toxicity of gold nanoparticles
Sung, J. H., Ji, J. H., Park, J. D., Song, M. Y., Song, K. S., Ryu, H. R., Yoon, J. U., Jeon, K. S., Jeong, J., Han, B. S., et al. (2011) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-8-16 · Cited by 158
Kinetics of gold nanoparticles in the human placenta
Myllynen, P. K., Loughran, M. J., Howard, C. V., Sormunen, R., Walsh, A. A., & Vähäkangas, K. H. (2008) · Reproductive Toxicology · doi:10.1016/j.reprotox.2008.06.008 · Cited by 158
Pharmacytes: An Ideal Vehicle for Targeted Drug Delivery
Freitas, R. A. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.413 · Cited by 155
Kemp, M. M., Kumar, A., Mousa, S. S., Dyskin, E., Yalçın, M., Ajayan, P. M., Linhardt, R. J., & Mousa, S. A. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/45/455104 · Cited by 155
Self-citationBagri, A., Tessier‐Lavigne, M., & Watts, R. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0563 · Cited by 154
Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT
Zhou, Y., Chakraborty, S., & Liu, S. (2011) · Theranostics · doi:10.7150/thno/v01p0058 · Cited by 149
Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era?
Pan, J. G., & Mak, T. W. (2007) · Science s STKE · doi:10.1126/stke.3812007pe14 · Cited by 147
Wei, Q., Ji, J., & Shen, J. (2008) · Macromolecular Rapid Communications · doi:10.1002/marc.200800009 · Cited by 144
Multifunctional Cytotoxic Stealth Nanoparticles. A Model Approach with Potential for Cancer Therapy
Schneider, G. F., Šubr, V., Ulbrich, K., & Decher, G. (2009) · Nano Letters · doi:10.1021/nl802990w · Cited by 144
Targeting Vascular NADPH Oxidase 1 Blocks Tumor Angiogenesis through a PPARα Mediated Mechanism
Garrido-Urbani, S., Jemelin, S., Deffert, C., Carnesecchi, S., Basset, O., Szyndralewiez, C., Heitz, F., Page, P., Montet, X., Michalik, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014665 · Cited by 143
Synthesis and Morphology of Star-Shaped Gold Nanoplates Protected by Poly(N-vinyl-2-pyrrolidone)
Yamamoto, M., Kashiwagi, Y., Sakata, T., Mori, H., & Nakamoto, M. (2005) · Chemistry of Materials · doi:10.1021/cm0515000 · Cited by 143
Gold Nanoparticles: Promising Nanomaterials for the Diagnosis of Cancer and HIV/AIDS
Kumar, A., Boruah, B. M., & Liang, X. (2011) · Journal of Nanomaterials · doi:10.1155/2011/202187 · Cited by 139
Self-citationEndoglin-Targeted Cancer Therapy
Seon, B. K., Haba, A., Matsuno, F., Takahashi, N., Tsujie, M., She, X., Harada, N., Uneda, S., Tsujie, T., Toi, H., et al. (2010) · Current Drug Delivery · doi:10.2174/156720111793663570 · Cited by 134
A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors
Stewart, D. J. (1994) · Journal of Neuro-Oncology · doi:10.1007/bf01052723 · Cited by 131
Aptamers for Targeted Drug Delivery
Ray, P., & White, R. R. (2010) · Pharmaceuticals · doi:10.3390/ph3061761 · Cited by 129
Structural basis for receptor recognition of vitamin-B12–intrinsic factor complexes
Andersen, C. B. F., Madsen, M. M., Storm, T., Moestrup, S. K., & Andersen, G. R. (2010) · Nature · doi:10.1038/nature08874 · Cited by 124
Polyacrylamide Nanoparticles as a Delivery System in Photodynamic Therapy
Kuruppuarachchi, M., Savoie, H., Lowry, A., Alonso, C., & Boyle, R. W. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200023y · Cited by 118
Maus, L., Dick, O., Bading, H., Spatz, J. P., & Fiammengo, R. (2010) · ACS Nano · doi:10.1021/nn101867w · Cited by 114
Production and performance of biomaterials containing RGD peptides
Perlin, L., MacNeil, S., & Rimmer, S. (2008) · Soft Matter · doi:10.1039/b801646a · Cited by 108
The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
Amini, A., Moghaddam, S. M., Morris, D. L., & Pourgholami, M. H. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912798888956 · Cited by 105
Solid colloidal drug delivery systems: Nanoparticles
Oppenheim, R. C. (1981) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(81)90100-9 · Cited by 102
Cyclic RGD Functionalized Gold Nanoparticles for Tumor Targeting
Arosio, D., Manzoni, L., Araldi, E. M. V., & Scolastico, C. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100448r · Cited by 96
Understanding barriers to drug delivery: high resolution in vivo imaging is key.
Jain, R. K. (1999) · PubMed · Cited by 86
Kalinina, J., Carroll, A., Wang, L., Yu, Q., Mancheno, D. E., Wu, S., Liu, F., Ahn, J. Y., He, M., Mao, H. Z., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0888-x · Cited by 84
Genomic instability of gold nanoparticle treated human lung fibroblast cells
Li, J. J., Lo, S., Ng, C.-T., Gurung, R. L., Hartono, D., Hande, M. P., Ong, C. N., Bay, B., & Yung, L. L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.023 · Cited by 81
Brain drug targeting: a computational approach for overcoming blood–brain barrier
Mehdipour, A. R., & Hamidi, M. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.009 · Cited by 78
Investigation of Cellular and Molecular Responses to Pulsed Focused Ultrasound in a Mouse Model
Burks, S. R., Ziadloo, A., Hancock, H. A., Chaudhry, A., Dean, D. D., Lewis, B. K., Frenkel, V., & Frank, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024730 · Cited by 77
“Metabolic Reprogramming” in Ovarian Cancer Cells Resistant to Cisplatin
Montopoli, M., Bellanda, M., Lonardoni, F., Ragazzi, E., Dorigo, P., Froldi, G., Mammi, S., & Caparrotta, L. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794328501 · Cited by 76
Przybytkowski, E., Behrendt, M., Dubois, D., & Maysinger, D. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07324.x · Cited by 74
Glial brain tumor targeting of magnetite nanoparticles in rats
Mykhaylyk, O. M., Черченко, А. П., Ilkin, A., Dudchenko, N. O., Ruditsa, V., Novoseletz, M., & Zozulya, Y. (2001) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(00)01264-6 · Cited by 74
Ngwa, W. F., Makrigiorgos, G. M., & Berbeco, R. I. (2010) · Physics in Medicine and Biology · doi:10.1088/0031-9155/55/21/013 · Cited by 72
Martell, L. A., Agrawal, A. C., Ross, D. A., & Muraszko, K. M. (1993) · PubMed · Cited by 71
Focşan, M., Ioan, A., Crăciun, C., & Aştilean, S. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/48/485101 · Cited by 71
Ge, Y., Bruno, M., Wallace, K., Winnik, W., & Prasad, R. Y. (2011) · PROTEOMICS · doi:10.1002/pmic.201000741 · Cited by 70
Akt signaling-associated metabolic effects of dietary gold nanoparticles in Drosophila
Wang, B., Chen, N., Wei, Y., Li, J., Sun, L. X., Wu, J., Huang, Q., Liu, C., Fan, C., & Song, H. (2012) · Scientific Reports · doi:10.1038/srep00563 · Cited by 66
Synthetic cell surface receptors for delivery of therapeutics and probes
Hymel, D., & Peterson, B. R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.02.007 · Cited by 63
Concise Review: Vascular Stem Cells and Tumor Angiogenesis
Melero‐Martin, J. M., & Dudley, A. C. (2010) · Stem Cells · doi:10.1002/stem.583 · Cited by 63
Prodrug Strategy for PSMA-Targeted Delivery of TGX-221 to Prostate Cancer Cells
Zhao, Y., Duan, S., Zeng, X., Liu, C., Davies, N. M., Li, B., & Forrest, M. L. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3000309 · Cited by 61
Cozzoli, P. D., Curri, M. L., Giannini, C., & Agostiano, A. (2006) · Small · doi:10.1002/smll.200500367 · Cited by 54
Models for predicting blood–brain barrier permeation
Nielsen, P. A., Andersson, O., Hansen, S. H., Simonsen, K. B., & Andersson, G. K. A. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.04.004 · Cited by 49
Xia, T., Rome, L. H., & Nel, A. E. (2008) · Nature Materials · doi:10.1038/nmat2213 · Cited by 45
Switching the Targeting Pathways of a Therapeutic Antibody by Nanodesign
Bhattacharyya, S., Singh, R. D., Pagano, R. E., Robertson, J. D., Bhattacharya, R., & Mukherjee, P. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201105432 · Cited by 44
Otto Heinrich Warburg, 1883-1970
Krebs, H. A. (1972) · Biographical Memoirs of Fellows of the Royal Society · doi:10.1098/rsbm.1972.0023 · Cited by 42
Rubenstein, S. M., Baichwal, V. R., Beckmann, H., Clark, D. L., Frankmoelle, W. P., Roche, D., Santha, E., Schwender, S., Thoolen, M., Ye, Q., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000478d · Cited by 40
New approaches to drug delivery through the blood-brain barrier
Pardridge, W. M. (1994) · Trends in biotechnology · doi:10.1016/0167-7799(94)90123-6 · Cited by 37
Stealth nanoparticles coated with heparin as peptide or protein carriers
Socha, M., Bartecki, P., Passirani, C., Sapin‐Minet, A., Damgé, C., Lecompte, T., Barré, J., El-Ghazouani, F., & Maincent, P. (2009) · Journal of drug targeting · doi:10.1080/10611860903112909 · Cited by 34
Antisense drug delivery through the blood-brain barrier
Boado, R. J. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00006-s · Cited by 32
Strategies for drug delivery through the blood-brain barrier
Pardridge, W. M. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90160-7 · Cited by 30
Physical barriers to drug delivery in tumors
Curti, B. D. (1993) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(93)90004-n · Cited by 27
Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth
Cantelmo, A. R., Cammarota, R., Noonan, D. M., Focaccetti, C., Comoglio, P. M., Prat, M., & Albini, A. (2010) · Oncogene · doi:10.1038/onc.2010.267 · Cited by 25
McCarthy, N. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3248 · Cited by 22
Blood-Brain Barrier Differentiation
Engelhardt, B. (2011) · Science · doi:10.1126/science.1216853 · Cited by 16
Drug delivery to the brain using colloidal carriers
Chang, J., Jallouli, Y., Barras, A., Dupont, N., & Betbeder, D. (2009) · Progress in brain research · doi:10.1016/s0079-6123(08)80001-5 · Cited by 15
Nanoparticle Contrast Agents for Cardiovascular Medical Imaging
Cormode, D. P., Klink, A., Fayad, Z. A., & Mulder, W. J. M. (2011) · Science Publishers eBooks · doi:10.1201/b11401-3 · Cited by 2
Cited by
Recent biomedical applications of gold nanoparticles: A review
Elahi, N., Kamali, M., & Baghersad, M. H. (2018) · Talanta · doi:10.1016/j.talanta.2018.02.088 · Cited by 1,174
Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles
Abadeer, N. S., & Murphy, C. J. (2016) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.5b11232 · Cited by 919
Unique Roles of Gold Nanoparticles in Drug Delivery, Targeting and Imaging Applications
Kong, F.-Y., Zhang, J.-W., Li, R.-F., Wang, Z.-X., Wang, W.-J., & Wang, W. (2017) · Molecules · doi:10.3390/molecules22091445 · Cited by 615
Review on nanomaterials: Synthesis and applications
Kolahalam, L. A., Kasi Viswanath, I. V., Diwakar, B. S., Govindh, B., Reddy, V., & Murthy, Y. L. N. (2019) · Materials Today: Proceedings · doi:10.1016/j.matpr.2019.07.371 · Cited by 592
Zaleska-Medynska, A., Marchelek, M., Diak, M., & Grabowska, E. (2016) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.12.008 · Cited by 540
Metadata
- Authors
- Kumar, A., Zhang, X., & Liang, X.-J.
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 31
- Issue
- 5
- Pages
- 593-606
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W2075585703
- Cited by
- 371
- References
- 198
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.